Arkema S.A. ARKAY has announced the inauguration of a next-generation acrylic acid purification unit at its Carling site in France, strengthening its competitive position in Europe’s market while advancing decarbonization. The nearly 150 million Euro investment is one of the company’s largest industrial projects in France and contributes to its ambitious climate investment program.
The new unit improves the energy efficiency of the purification process by 25% and reduces the carbon intensity of the Carling site by 20%. Its innovative technology also optimizes resource and waste management while significantly lowering solvent consumption. These improvements enhance efficiency to reinforce Arkema’s position in the low-carbon acrylic materials market.
The Carling facility is a leading acrylic production site, manufacturing acrylic monomers used in performance coatings, adhesives, water treatment and other advanced materials. The project, decided in 2023, received partial funding from the French State under the France 2030 program, operated by ADEME, and from the European Union’s NextGenerationEU initiative.
The cumulative investments could reach €400 million over 2022-2030, under the company’s decarbonization plans, while making its industrial hubs the driving forces of future. Arkema’s investment also aligns with its strategy to strengthen its Specialty Materials segment and its increasing focus on reducing emissions across the industry.
ARKAY shares have gained 5.5% in the past year compared with the industry’s 0.1% rise in the same period.
Image Source: Zacks Investment Research
ARKAY’s Zacks Rank & Key Picks
ARKAY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Aperam S.A. APEMY, Reliance, Inc. RS and Axalta Coating Systems Ltd. AXTA.
APEMY sports a Zacks Rank #1 (Strong Buy) while RS and AXTA carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here
The Zacks Consensus Estimate for APEMY’s current fiscal-year earnings is pinned at $3.30 per share. APEMY’sshares have gained 15% over the past year.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.70 per share, indicating a 66.2% year-over-year increase. RS’shares have gained 46.1% over the past year.
The Zacks Consensus Estimate for AXTA’s fiscal 2026 earnings is pegged at $2.63 per share, indicating a rise of 5.62% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 6.45%.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Arkema SA (ARKAY): Free Stock Analysis Report
Reliance, Inc. (RS): Free Stock Analysis Report
Axalta Coating Systems Ltd. (AXTA): Free Stock Analysis Report
Aperam (APEMY): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).